Clinical Trial Update: Immuno-inflammatory Response of Erdosteine in COPD [NA]

View source ↗

Summary

A clinical trial update for Erdosteine in chronic obstructive pulmonary disease, assessing immuno-inflammatory response. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Erdosteine (erdosteine)

Snippet

Sponsor: Pierachille Santus, MD, PhD | Conditions: COPD | NA | Status: NOT_YET_RECRUITING